Alto Neuroscience (ANRO) went public on the NYSE today. CEO Amit Etkin joins Nicole Petallides to give an overview of the company. Alto Neuroscience is a clinical-stage biopharmaceutical company that develops treatments for mental health. Tune in to find out more about the stock market today.
The Watch List
02 Feb 2024
SHARE
Current show
Mon—Fri at 3:30 pm — 4:00 pm
Market Overtime